Copenhagen, Denmark

Ulrike Leurs

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Otago Innovation Limited, University of Copenhagen. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ulrike Leurs: Innovator in Acute Brain Injury Treatment

Introduction

Ulrike Leurs is a prominent inventor based in Copenhagen, Denmark. She has made significant contributions to the field of medical research, particularly in the treatment of acute brain injuries. Her innovative work has led to the development of a unique compound that holds promise for improving patient outcomes.

Latest Patents

Ulrike Leurs holds 1 patent for her invention titled "Compounds for the treatment of acute brain injury." This invention relates to a compound defined by a specific formula, which includes variations based on the structural configuration of the compound. The potential applications of her invention could greatly benefit those suffering from acute brain injuries.

Career Highlights

Throughout her career, Ulrike has worked with esteemed institutions such as the University of Copenhagen and Otago Innovation Limited. Her work in these organizations has allowed her to advance her research and collaborate with other experts in the field.

Collaborations

Ulrike has collaborated with notable colleagues, including Anders Bue Klein and Andrew Neil Clarkson. These partnerships have enriched her research and contributed to the development of her innovative solutions.

Conclusion

Ulrike Leurs is a trailblazer in the field of medical innovation, particularly in the treatment of acute brain injuries. Her contributions through her patent and collaborations highlight her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…